NCT07008794View on ClinicalTrials.gov

Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

March 31, 2023

Conditions

Acute Coronary Syndromes

Interventions

DRUG

Atorvastatin 40 mg

Rosuvastatin 20 mg

Trial Locations (1)

71515

Assiut University Heart Hospital, Asyut

All Listed Sponsors

lead

Assiut University

OTHER